Klaus P. Hoeflich
Klaus P. Hoeflich publishes mostly in Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, on topics such as Melanoma and MAPK Pathways, Cancer-related Molecular Pathways and Protein Kinase Regulation and GTPase Signaling.
- World rank
- #79,029 of 7,710,434 ranked researchers
- Rank in United States
- #30,470 of 1,627,098
- Works
- 279
- Citations
- 12k
- Citations per work
- 42.1
What does Klaus P. Hoeflich research?
Klaus P. Hoeflich's work is mostly in Biochemistry, Genetics and Molecular Biology (43%), Medicine (30%), Chemistry (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences12143.4%
- Health Sciences8530.3%
- Medicine8530.3%
- Everything else6322.6%
- Physical Sciences103.7%
- Chemistry103.7%
- 1Molecular Biology39% of their works
- 2Oncology19% of their works
- 3Pulmonary and Respiratory Medicine6% of their works
- 4Pathology and Forensic Medicine5% of their works
- 5Cancer Research4% of their works
- 6Organic Chemistry4% of their works
Research topics
Which keywords describe Klaus P. Hoeflich's research?
The keywords of their largest research topics: Cancer Therapy, Oncogenic Mutations, BRAF gene, MAP Kinase, Cell Cycle, p53, Cancer and Signaling.
- Fibroblast Growth Factor
- Virtual Screening
- mTOR
- Tumorigenesis
- Pim Oncogenes
- Ras Signaling
- Signaling
- p53
- MAP Kinase
- Oncogenic Mutations
- Cancer Therapy
- BRAF gene
- Cell Cycle
- Cancer
- Protein Kinases
- EGFR Mutations
- Targeted Therapy
- PI3K/AKT pathway
- Molecular Docking
- FGF21
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Cancer Therapy743 topics
- Oncogenic Mutations522 topics
- BRAF gene361 topic
- MAP Kinase361 topic
- Cell Cycle221 topic
- p53221 topic
- Cancer192 topics
- Signaling192 topics
- Protein Kinases161 topic
- Ras Signaling161 topic
- EGFR Mutations131 topic
- Pim Oncogenes131 topic
- Targeted Therapy131 topic
- Tumorigenesis131 topic
- PI3K/AKT pathway121 topic
- mTOR121 topic
- Molecular Docking81 topic
- Virtual Screening81 topic
- FGF2171 topic
- Fibroblast Growth Factor71 topic
Where does Klaus P. Hoeflich work?
Klaus P. Hoeflich's main affiliation in the publication record is Blueprint Medicines (United States), United States.
How many publications and citations does Klaus P. Hoeflich have?
OpenAlex counts 279 works and 11,758 citations for Klaus P. Hoeflich, an h-index of 48, ranking #79,029 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Klaus P. Hoeflich. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.